PensionBee Group Valuation

Is 6HD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6HD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 6HD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 6HD's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6HD?

Key metric: As 6HD is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 6HD. This is calculated by dividing 6HD's market cap by their current revenue.
What is 6HD's PS Ratio?
PS Ratio12.5x
SalesUK£28.32m
Market CapUK£355.26m

Price to Sales Ratio vs Peers

How does 6HD's PS Ratio compare to its peers?

The above table shows the PS ratio for 6HD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.5x
MUX Mutares SE KGaA
0.09x10.5%€484.6m
AR4 AURELIUS Equity Opportunities SE KGaA
0.1xn/a€392.2m
HXCK Ernst Russ
1.1x-4.4%€196.1m
O4B OVB Holding
0.7x3.9%€283.6m
6HD PensionBee Group
12.5x20.7%€355.3m

Price-To-Sales vs Peers: 6HD is expensive based on its Price-To-Sales Ratio (12.5x) compared to the peer average (0.5x).


Price to Sales Ratio vs Industry

How does 6HD's PS Ratio compare vs other companies in the DE Capital Markets Industry?

22 CompaniesPrice / SalesEstimated GrowthMarket Cap
MLP MLP
0.6x2.3%US$672.51m
MUX Mutares SE KGaA
0.09x10.5%US$508.01m
AR4 AURELIUS Equity Opportunities SE KGaA
0.2x0.01%US$500.05m
AR4 AURELIUS Equity Opportunities SE KGaA
0.1xn/aUS$411.15m
6HD 12.5xIndustry Avg. 2.8xNo. of Companies22PS048121620+
22 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 6HD is expensive based on its Price-To-Sales Ratio (12.5x) compared to the German Capital Markets industry average (2.8x).


Price to Sales Ratio vs Fair Ratio

What is 6HD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6HD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio12.5x
Fair PS Ratio2.1x

Price-To-Sales vs Fair Ratio: 6HD is expensive based on its Price-To-Sales Ratio (12.5x) compared to the estimated Fair Price-To-Sales Ratio (2.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6HD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.65
€2.41
+45.8%
10.4%€2.61€1.98n/a4
Nov ’25€1.78
€2.41
+35.2%
10.4%€2.61€1.98n/a4
Oct ’25€1.95
€2.30
+17.9%
9.7%€2.50€1.96n/a4
Sep ’25€1.87
€2.30
+22.9%
9.7%€2.50€1.96n/a4
Aug ’25€1.86
€2.30
+23.6%
9.7%€2.50€1.96n/a4
Jul ’25€1.90
€1.84
-3.0%
12.2%€2.01€1.46n/a4
Jun ’25€1.65
€1.84
+11.7%
12.2%€2.01€1.46n/a4
May ’25€1.71
€1.84
+7.8%
12.2%€2.01€1.46n/a4
Apr ’25€1.20
€1.66
+38.3%
18.8%€1.99€1.25n/a4
Mar ’25€1.00
€1.66
+66.0%
18.8%€1.99€1.25n/a4
Feb ’25€1.07
€1.66
+55.3%
15.6%€1.95€1.38n/a4
Jan ’25€1.02
€1.66
+62.9%
15.6%€1.95€1.38n/a4
Dec ’24€0.80
€1.66
+107.7%
15.6%€1.95€1.38n/a4
Nov ’24€0.66
€1.66
+151.8%
15.6%€1.95€1.38€1.784
Oct ’24€0.77
€1.73
+124.6%
17.8%€2.09€1.40€1.954
Sep ’24€0.79
€1.73
+120.3%
17.8%€2.09€1.40€1.874
Aug ’24€0.81
€1.73
+114.9%
17.8%€2.09€1.40€1.864
Jul ’24€0.80
€1.73
+116.2%
17.8%€2.09€1.40€1.904
Jun ’24€0.73
€1.88
+155.6%
24.4%€2.62€1.37€1.655
May ’24€0.90
€1.88
+108.7%
24.4%€2.62€1.37€1.715
Apr ’24€1.00
€1.81
+80.7%
32.1%€2.61€0.85€1.205
Mar ’24€0.94
€1.79
+90.2%
32.8%€2.47€0.86€1.004
Feb ’24€0.68
€1.79
+164.8%
32.8%€2.47€0.86€1.074
Jan ’24€0.57
€1.85
+221.8%
7.3%€1.97€1.62€1.024
Dec ’23€0.63
€1.85
+193.7%
7.3%€1.97€1.62€0.804
Nov ’23€0.67
€1.95
+193.5%
14.7%€2.39€1.60€0.664

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies